Skip to main content
. 2022 Dec 8;9:979334. doi: 10.3389/fmed.2022.979334

TABLE 2.

Ophthalmology examination between the orthokeratology (OK) group and control group after 12 months.

OK group (12 months) Control group (12 months) P-value
SE (D), mean ± SD 40.97 ± 0.87 43.24 ± 0.99 0.980
AL (mm), mean ± SD 24.21 ± 0.57 24.40 ± 0.61 0.148
AL growth (mm), mean ± SD 0.07 ± 0.01 0.21 ± 0.03 <0.001*
Corneal apical power (D), mean ± SD 41.32 ± 0.96 43.58 ± 1.10 0.466
Corneal apical power change (D), mean ± SD 2.20 ± 0.60 0.03 ± 0.28 <0.001*
Corneal equivalent power (D), mean ± SD 41.64 ± 0.87 43.19 ± 1.02 0.472
Corneal equivalent change (D), mean ± SD 2.28 ± 1.04 0.73 ± 0.40 <0.001*
Corneal keratometry astigmatism (D), mean ± SD 0.69 ± 0.58 0.67 ± 0.48 0.280
CECC, mean ± SD 2807.49 ± 95.85 2780.68 ± 95.94 0.852
IOP (mmHg), mean ± SD 15.13 ± 1.55 14.60 ± 1.55 0.955
Naked eye vision, mean ± SD −0.02 ± 0.06 0.79 ± 0.35 <0.001*
TBUT (s), mean ± SD 11.97 ± 1.08 12.00 ± 0.82 0.914

AL, axial length; CECC, corneal endothelial cell count; D, diopter; IOP, intraocular pressure; OK, orthokeratology; SE, spherical equivalent; TBUT, tear break-up time, SD, standard deviation.

Independent sample t-test.

*Statistically significant.

Bold values indicate P < 0.05.